Laughing Water Capital’s Updates on Liquidia Corp (LQDA)
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter.
Liquidia Corp (LQDA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 8,565,638 | $194,782,608 | +103% | 0.8% |
| 2. | Caligan Partners David Johnson | 8,118,892 | $184,623,604 | 24.18% | |
| 3. | Findell Capital Management Brian Finn | 2,830,000 | $64,354,200 | -6% | 25.4% |
| 4. | Opaleye Management James A. Silverman | 2,615,000 | $59,465,100 | +6% | 8.41% |
| 5. | 2,000,000 | $45,480,000 | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.90 | 337,078 | $2,999,994.20 | 816,311 | 2024-09-12 | Filing | |
| $9.51 | 150,000 | $1,426,500.00 | 6,994,997 | 2024-08-30 | Filing | |
| $7.16 | 139,665 | $1,000,001.40 | 640,805 | 2023-12-14 | Filing | |
| $7.16 | 279,330 | $2,000,002.80 | 279,330 | 2023-12-14 | Filing | |
| $7.16 | 1,117,318 | $7,999,996.88 | 11,280,945 | 2023-12-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.65 | 1,580 | $65,807.00 | 178,848 | 2026-01-26 | Filing | |
| $41.65 | 688 | $28,655.20 | 211,169 | 2026-01-26 | Filing | |
| $37.43 | 13,165 | $492,765.95 | 140,769 | 2026-01-12 | Filing | |
| $37.43 | 20,533 | $768,550.19 | 154,514 | 2026-01-12 | Filing | |
| $37.43 | 36,932 | $1,382,364.76 | 350,919 | 2026-01-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,013,888 | $138,438,996 | 0% | |
| 2. | 1,783,921 | $61,527,435 | 1.3% | |
| 3. | 141,818 | $4,891,303 | 0.56% | |
| 4. | 111,762 | $3,854,671 | 0% | |
| 5. | 63,030 | $2,173,905 | 0.06% |
News See All
Arquitos Capital Management’s Updates on Liquidia Corporation (LQDA)
Arquitos Capital Management, an investment management firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA’s 75% Growth in U.S. Prostacyclin Revenue
On November 4, 2025, Raymond James raised its price target on Liquidia Corporation (NASDAQ:LQDA) from $41 to $47, while reiterating a “Strong Buy” rating.
10 Best Small-Cap Biotech Stocks to Buy According to Analysts
Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention.
Liquidia (LQDA) Climbs 10.7%, Nears 52-Week High on Strong Demand for Heart Treatment
Liquidia soared by 10.67 percent on Tuesday to close at $27.91 apiece, just 92 cents shy of its highest 52-week price, as investor sentiment was bolstered by strong demand for its pulmonary hypertension...
Liquidia Corporation (NASDAQ:LQDA) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Liquidia Corporation Third Quarter 2025 Financial Results and Corporate Update Conference Call.
BofA Securities Raises Liquidia Corporation (LQDA) PT to $37, Reiterates Buy Rating
Liquidia Corporation (NASDAQ:LQDA) is one of the best hot stocks to invest in. On October 9, BofA raised the firm’s price target on Liquidia to $37 from $35 and kept a Buy rating on the shares.
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
11 Best Performing Long Term Stocks According to Analysts
Alli McCartney of UBS noted that the market’s behavior after the recent Fed rate cut was unusual. On the day of the cut, major indices closed lower except for the Russell 2000.
Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares?
Arquitos Capital Management, an investment management firm, released its second-quarter 2025 investor letter.